Party Drug Ketamine (Special K) Likely To Become Anti-Depression Medicine
The drug Ketamine, known in the party scene as "Special K," could have a future in depression treatment. Pharmaceutical companies are racing to create a patentable version of the drug and researchers are trying to learn more about the effects it has on the brain. Ketamine works by blocking the signalling molecule NMDA, which is a component of the glutamate pathway. This pathway is involved with memory and cognition, psychiatrist James Murrough at the Mount Sinai Hospital in New York City, explained to Nature magazine.
- Dr. James Murrough, Assistant Professor, Psychiatry, Neuroscience, Icahn School of Medicine at Mount Sinai
Researchers Develop AI Model That Maps How Genes Work Together in Human Cells
May 21, 2026 View All Press Releases
Study Reveals “Bet-Hedging” Strategy That Helps Gut Bacteria Survive and Recover
May 19, 2026 View All Press Releases
Reversing T Cell Exhaustion Improves Effectiveness of Myeloma Immunotherapies
May 18, 2026 View All Press Releases
A Promising Study Suggests a Blood Test Could Spot Alzheimer’s Early in Progression
Apr 21, 2026 View All Press Releases